Scelo Mguni, Felistas Mashinya, Collette Khabo-Mmekoa, Lishweni J. Shai
{"title":"花椒的民族药用、药理学、植物化学和毒理学研究综述","authors":"Scelo Mguni, Felistas Mashinya, Collette Khabo-Mmekoa, Lishweni J. Shai","doi":"10.4102/jomped.v7i1.202","DOIUrl":null,"url":null,"abstract":"Background: Zanthoxylum chalybeum Engl. is a traditional medicinal plant, which is native to Eastern and Southern Africa. Commonly known as the ‘Knob wood’, it has been used for centuries by several traditional healers in Kenya, Tanzania, Uganda, Zambia and Zimbabwe. The species is very well known to local communities by its common names such as ‘Kundanyoka’ (Shona), ‘Mjafari’ (Swahili) and ‘Ntaleyedungu’ (Uganda), and it grows naturally in the tropics and subtropics. Aim: The present review describes information on the ethnomedicinal uses, phytochemical constituents, pharmacology and toxicology of Z. chalybeum . Method: Collection of data was based on literature research from several sources including electronic databases such as Google scholar, Web of Science, Science Direct, Pubmed, books, book chapters and theses. Results: Z. chalybeum is widely used in the treatment of malaria, cancer and diabetes. Pharmacological studies revealed that crude extracts and some isolated chemical compounds from Z. chalybeum demonstrated biological activities such as antibacterial, antidiabetic and antimalarial activities. Studies in phytochemical analysis of Z. chalybeum revealed the presence of new compounds such as 6-benzo (1, 3) dioxol-5-yl-hexa-2,5 dienoic acid isobutylamide, 4-methoxy-N-(2-methoxy-phenyl)-N methyl-benzamide, N-(2-hydroxy-methyl-propyl)-3 phenyl-acrylamide and 4-(isoprenyloxy)-3-methoxy,4-deoxymethylenedioxyfagaramide. Toxicology studies revealed moderate to high toxicity, depending on the type of cells and the extraction solvent used. Conclusion: Z. chalybeum is a valued medicinal plant used in Eastern and Southern Africa. Contribution: The properties of Z. chalybeum revealed in previous studies can be used to guide research scientists in future drug formulations.","PeriodicalId":16345,"journal":{"name":"Journal of Medicinal Plants for Economic Development","volume":"48 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A review of Zanthoxylum chalybeum Engl: Ethnomedicinal uses, pharmacology, phytochemistry and toxicology\",\"authors\":\"Scelo Mguni, Felistas Mashinya, Collette Khabo-Mmekoa, Lishweni J. Shai\",\"doi\":\"10.4102/jomped.v7i1.202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Zanthoxylum chalybeum Engl. is a traditional medicinal plant, which is native to Eastern and Southern Africa. Commonly known as the ‘Knob wood’, it has been used for centuries by several traditional healers in Kenya, Tanzania, Uganda, Zambia and Zimbabwe. The species is very well known to local communities by its common names such as ‘Kundanyoka’ (Shona), ‘Mjafari’ (Swahili) and ‘Ntaleyedungu’ (Uganda), and it grows naturally in the tropics and subtropics. Aim: The present review describes information on the ethnomedicinal uses, phytochemical constituents, pharmacology and toxicology of Z. chalybeum . Method: Collection of data was based on literature research from several sources including electronic databases such as Google scholar, Web of Science, Science Direct, Pubmed, books, book chapters and theses. Results: Z. chalybeum is widely used in the treatment of malaria, cancer and diabetes. Pharmacological studies revealed that crude extracts and some isolated chemical compounds from Z. chalybeum demonstrated biological activities such as antibacterial, antidiabetic and antimalarial activities. Studies in phytochemical analysis of Z. chalybeum revealed the presence of new compounds such as 6-benzo (1, 3) dioxol-5-yl-hexa-2,5 dienoic acid isobutylamide, 4-methoxy-N-(2-methoxy-phenyl)-N methyl-benzamide, N-(2-hydroxy-methyl-propyl)-3 phenyl-acrylamide and 4-(isoprenyloxy)-3-methoxy,4-deoxymethylenedioxyfagaramide. Toxicology studies revealed moderate to high toxicity, depending on the type of cells and the extraction solvent used. Conclusion: Z. chalybeum is a valued medicinal plant used in Eastern and Southern Africa. Contribution: The properties of Z. chalybeum revealed in previous studies can be used to guide research scientists in future drug formulations.\",\"PeriodicalId\":16345,\"journal\":{\"name\":\"Journal of Medicinal Plants for Economic Development\",\"volume\":\"48 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Plants for Economic Development\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4102/jomped.v7i1.202\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Economics, Econometrics and Finance\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Plants for Economic Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/jomped.v7i1.202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Economics, Econometrics and Finance","Score":null,"Total":0}
引用次数: 0
摘要
背景:Zanthoxylum chalybeum Engl。是一种传统的药用植物,原产于非洲东部和南部。它通常被称为“旋钮木”,几个世纪以来一直被肯尼亚、坦桑尼亚、乌干达、赞比亚和津巴布韦的一些传统治疗师使用。该物种因其常见的名称而为当地社区所熟知,如“Kundanyoka”(绍纳语),“Mjafari”(斯瓦希里语)和“Ntaleyedungu”(乌干达),它自然生长在热带和亚热带地区。前言:目的:综述了黄姜的民族医药用途、植物化学成分、药理和毒理学等方面的研究进展。方法:采用Google scholar、Web of Science、Science Direct、Pubmed等电子数据库、图书、图书章节、论文等文献资料收集数据。结果:黄芩在治疗疟疾、癌症、糖尿病等方面有广泛的应用。药理研究表明,黄樟粗提物及部分分离化合物具有抗菌、抗糖尿病、抗疟疾等生物活性。在植物化学分析中发现了6-苯并(1,3)二氧基-5-基-六-2,5二烯酸异丁酰胺、4-甲氧基-N-(2-甲氧基-苯基)-N -甲基-苯甲酰胺、N-(2-羟基-甲基-丙基)-3苯基-丙烯酰胺和4-(异戊氧基)-3-甲氧基,4-脱氧亚甲二氧基fagaramide等新化合物。毒理学研究显示,根据细胞类型和提取溶剂的不同,其毒性从中等到高不等。结论:白姜是非洲东部和南部一种珍贵的药用植物。贡献:前人研究揭示的黄樟的性质可用于指导研究人员在未来的药物配方。
A review of Zanthoxylum chalybeum Engl: Ethnomedicinal uses, pharmacology, phytochemistry and toxicology
Background: Zanthoxylum chalybeum Engl. is a traditional medicinal plant, which is native to Eastern and Southern Africa. Commonly known as the ‘Knob wood’, it has been used for centuries by several traditional healers in Kenya, Tanzania, Uganda, Zambia and Zimbabwe. The species is very well known to local communities by its common names such as ‘Kundanyoka’ (Shona), ‘Mjafari’ (Swahili) and ‘Ntaleyedungu’ (Uganda), and it grows naturally in the tropics and subtropics. Aim: The present review describes information on the ethnomedicinal uses, phytochemical constituents, pharmacology and toxicology of Z. chalybeum . Method: Collection of data was based on literature research from several sources including electronic databases such as Google scholar, Web of Science, Science Direct, Pubmed, books, book chapters and theses. Results: Z. chalybeum is widely used in the treatment of malaria, cancer and diabetes. Pharmacological studies revealed that crude extracts and some isolated chemical compounds from Z. chalybeum demonstrated biological activities such as antibacterial, antidiabetic and antimalarial activities. Studies in phytochemical analysis of Z. chalybeum revealed the presence of new compounds such as 6-benzo (1, 3) dioxol-5-yl-hexa-2,5 dienoic acid isobutylamide, 4-methoxy-N-(2-methoxy-phenyl)-N methyl-benzamide, N-(2-hydroxy-methyl-propyl)-3 phenyl-acrylamide and 4-(isoprenyloxy)-3-methoxy,4-deoxymethylenedioxyfagaramide. Toxicology studies revealed moderate to high toxicity, depending on the type of cells and the extraction solvent used. Conclusion: Z. chalybeum is a valued medicinal plant used in Eastern and Southern Africa. Contribution: The properties of Z. chalybeum revealed in previous studies can be used to guide research scientists in future drug formulations.